Collectively, our data provide evidence for a previously uncovered tumor-suppressor function of ATGL in HCC, with the outlined molecular mechanisms shedding light on new potential targets for anticancer therapy. The gene discussed is PNPLA2; the disease is hepatocellular carcinoma.